Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of non-incretin products, which grew sales 20% in the fourth quarter, should “help ...

Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...

Garden suites located in rear yards behind a single detached house, a semi-detached house and a townhouse or low-rise apartment block. Ontario Regulation 462/24 came into force on November 20, 2024.

Conagra is showing signs of a turnaround with improving shipment volumes, organic sales growth, and a rising market share in ...

Growing demand for weight-loss solutions has catapulted pharmaceutical firms like Eli Lilly (LLY) and Novo Nordisk (NVO) into ...

Kenox Pharmaceuticals Inc., a company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), has ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

Join a suite of experts from across the industry Jan. 29 for a free online event examining the opportunities and challenges ...

“The goal of our study would be to prove that, by combining the Allurion Balloon and Allurion Virtual Care Suite with GLP-1 therapy, patients can lose significant weight while increasing muscle ...

The Company’s GLP-1-like alternatives are currently being ... The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known ...